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 العالقة بني االلتزام باألدوية واملعتقدات بني املرضى الذين يعانون
من ارتفاع ضغط الدم يف عمان
دراسة ارتيادية
هدى النعمانية، جيا رونغ وو، ديربا بارك�سديل، اإ�رصاء اخل�ساونة، جورج كنافل، جوين �سريوود
abstract: Objectives: The prevalence of hypertension (HTN) in Oman is alarmingly high and patient adherence 
to antihypertensive medications is inadequate. This study aimed to assess the relationship between medication 
adherence and health beliefs among Omani patients with HTN. Methods: This descriptive cross-sectional 
pilot study was conducted in December 2015 and included 45 patients with HTN recruited from four primary 
health centres in Al Dakhiliyah and Muscat governorates, Oman. Medication adherence and health beliefs were 
assessed using the Morisky Medication Adherence Scale (MMAS), Beliefs about Medicines Questionnaire, Brief 
Illness Perception Questionnaire and the revised Medication Adherence Self-Efficacy Scale. Results: The mean 
MMAS score was 5.3 ± 2.0, with 48.9% of patients reporting high adherence. Higher self-efficacy and stronger 
beliefs regarding medication necessity were significantly related to adherence (P = 0.012 and 0.028, respectively). 
Conclusion: The findings of this pilot study emphasise the role of health beliefs with regards to Omani patients’ 
adherence to antihypertensive medications.
Keywords: Hypertension; Health Behavior; Medication Adherence; Self Efficacy; Oman.
امللخ�ص: الهدف: يعترب معدل انت�سار ارتفاع �سغط الدم يف عمان مرتفعا ب�سكل مثري للجزع والتزام املري�ص باالأدوية اخلاف�سة لل�سغط 
غري كاف. تهدف هذه الدرا�سة اإىل تقييم العالقة بني االلتزام باالأدوية واملعتقدات ال�سحية لدى املر�سى العمانيني امل�سابني بارتفاع 
اأربعة  اختيارهم من  45 مري�سا مت  و�سملت   ،2015 دي�سمرب  املقطعية يف  الو�سفية  االرتيادية  الدرا�سة  اأجريت هذه  الطريقة:  الدم.  �سغط 
مراكز �سحية اأولية يف حمافظتي الداخلية وم�سقط، يف عمان. مت تقييم االلتزام باالأدوية واملعتقدات ال�سحية با�ستخدام مقيا�ص موري�سكي 
باالأدوية.  لاللتزام  الذاتية  الكفاءة  وا�ستبيان  وجيزة  لفرتة  ت�سوراملر�ص  ا�ستبيان  االأدوية،  حول  املعتقدات  ا�ستبيان  باالأدوية،  لاللتزام 
النتائج: كان متو�سط درجة مقيا�ص موري�سكي 2.0 ± 5.3، مع %48.9 من املر�سى اأبلغوا عن درجة التزام عالية. كما اأن ارتفاع الكفاءة 
0.028، على  )P = 0.012 و  ارتباطا كبريا بااللتزام باالأدوية  االأدوية ترتبط  باأهمية  ال�سحية  الذاتية لاللتزام باالأدوية وقوة املعتقدات 
التوايل(. اخلال�صة: توؤكد نتائج هذه الدرا�سة على دور املعتقدات ال�سحية فيما يتعلق بالتزام املر�سى العمانيني باالأدوية اخلاف�سة لل�سغط.
الكلمات املفتاحية: ارتفاع �سغط الدم؛ ال�سلوك ال�سحي؛ االلتزام باالأدوية؛ الكفاءة الذاتية؛ عمان.
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The global prevalence of hypertension (HTN) is projected to increase markedly by 2025.1 Poor HTN management increases 
healthcare expenditure and complication, mortality 
and morbidity rates; as such, medication adherence is 
key.1 However, patient adherence to antihypertensive 
medications is inadequate globally.1 Patient beliefs 
about health and illness are significant predictors of 
medication adherence.2 Moreover, beliefs regarding 
the severity of a disease, self-efficacy and the benefits 
of medication may explain patients’ attitudes towards 
medication adherence, as described in the Health 
Beliefs Model.3 
In Oman, the prevalence of HTN is high, with up 
to 40% of the population affected.4 Among those with 
HTN, 5% have severe HTN (i.e. systolic blood pressure 
of ≥180 mmHg or diastolic blood pressure of ≥110 
mmHg).4 While several studies in Oman have focused 
on understanding HTN-related risk factors, none to 
date have examined the relationship between patients’ 
health beliefs and their adherence to antihypertensive 
medications.5,6 Greater knowledge of the health beliefs 
and medication habits of Omani patients with HTN 
may help clinicians and researchers develop strategies 
to foster medication adherence and enhance HTN 
management. This pilot study therefore aimed to 
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describe medication adherence, self-efficacy and 
health beliefs among Omani patients with HTN and 
subsequently examine the relationship between health 
beliefs and medication adherence.
Methods
This descriptive cross-sectional pilot study was 
conducted in December 2015. Adult patients with 
HTN aged ≥21 years old were recruited from four 
primary health centres in the Al Dakhiliyah and 
Muscat governorates in Oman. All participants had 
been diagnosed with HTN by their primary physician 
at least one year prior to the study and had been 
prescribed at least one antihypertensive medication. 
Patients were screened for eligibility according to their 
medical records; those with comorbidities such as 
diabetes, heart disease or asthma were subsequently 
excluded from the study. The sample size was set at 45 
with 80% power in order to identify an R2 of ≥15.4% 
for the bivariate regression analyses and ≥23% for the 
multiple regression analysis based on four predictors. 
Consequently, the regression analyses were only 
powered to identify relatively large effect sizes.
All participants were asked to complete a 
demographic form and four questionnaires, including 
Arabic versions of the 8-item Morisky Medication 
Adherence Scale (MMAS) to measure adherence and 
three different health beliefs questionnaires reflecting 
the basic premises of the Health Beliefs Model 
(i.e. perceived self-efficacy, severity of the disease 
and the necessity of and concerns regarding the 
mediciation).3,7–12 For the MMAS, scores ranged from 
0–8 with a cut-off value for adequate adherence set at 
≥6 for the purposes of the current study.7 Beliefs about 
medication necessity and concerns were measured 
using two subscales of a validated Arabic version of 
the Beliefs about Medicines Questionnaire (BMQ) 
obtained from the main developer of the original 
11-item questionnaire, similarly scored on a five-
point Likert scale.10,12 Beliefs about HTN severity were 
measured using the 8-item Brief Illness Perception 
Questionnaire (BIPQ), in which each item was rated 
on a scale of 0–10, with the overall score ranging 
from 0–80.9 Self-efficacy for medication adherence 
was measured using the 13-item revised Medication 
Adherence Self-Efficacy Scale (MASES-R), with 
each item rated using a four-point Likert scale.8 
For all questionnaires, higher scores reflect greater 
adherence, stronger beliefs and greater self-efficacy, 
respectively; in addition, previous research has 
confirmed the validity and reliability of these tools.7–11 
Permission to use these questionnaires was obtained 
from the relevant developers, including permission to 
use the Arabic versions of the tools. Only the BIPQ 
and MASES-R questionnaires were translated to 
Arabic by the researchers themselves; this was done 
using previously described translation methods.13
Descriptive statistics including means, standard 
deviations, frequencies and percentages were 
computed using the Statistical Package for the Social 
Sciences (SPSS), Version 23.0 (IBM Corp., Armonk, 
New York, USA). Relationships between demographic 
characteristics, health beliefs and medication 
adherence were assessed using a bivariate Pearson’s 
correlation analysis for continuous variables and a one-
way analysis of variance test for categorical variables. 
Multiple linear regression analysis was conducted 
to examine the independent influence of beliefs on 
medication adherence. Variables were input into the 
regression analysis model using the enter method. A 
P value of ≤0.050 was considered statistically 
significant. 
Ethical approval for this pilot study was obtained 
from both the University of North Carolina at Chapel 
Hill, Chapel Hill, North Carolina, USA (IRB #15-0684), 
and the Research and Ethical Review and Approval 
Committee of the Ministry of Health in Muscat. All 
of the participants provided informed written consent 
prior to their inclusion in the pilot study.
Results
A total of 45 patietns were included in this pilot study. 
Table 1 illustrates the demographic characteristics 
of the participants. The mean MMAS score was 
5.3 ± 2.0 and 48.9% of the subjects were classified as 
high adherers. In total, 95.6% reported that they had 
not missed a medication dose over the previous two 
weeks, 66.7% claimed that they were never annoyed 
about complying with their medication requirements, 
64.4% reported never cutting back or stopping their 
medications without informing their doctor and 64.4% 
stated that they continued to take their medications 
when travelling. Moreover, 50.0% of the subjects 
reported they had no difficulty remembering to take 
their medications.
The mean score for the necessity subscale of 
the BMQ was 3.8 ± 0.8. Most subjects agreed to the 
following: that their current (88.9%) and future (55.5%) 
health depended on the medication; that medications 
protected their health from becoming worse (84.4%); 
and that, without the medication, they would become 
very ill (57.8%). However, 33.3% of the subjects were 
uncertain as to whether their future health depended 
on the medications and whether their lives would be 
impossible without the medicine. The mean score 
for the concerns subscale of the BMQ was 2.7 ± 0.7. 
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More than half of the subjects disagreed or strongly 
disagreed with the following statements: that the 
antihypertensive medicine disrupted their life 
(68.2%); that having to take the medication worried 
them (57.8%); and that the medicine had unpleasant 
side-effects (51.1%). However, some of the subjects 
reported concerns about becoming too dependent on 
the medication (44.4%) and that the medication was a 
mystery to them (35.5%).
The mean BIPQ score was 27.0 ± 12.2. A total of 
70.0% of the subjects reported that HTN had minimal 
or no effect on their lives; 100.0% believed that they 
had control over their HTN; 66.7% believed that they 
had few or no symptoms of HTN; and 72.7% reported 
having minimal or no concern regarding their HTN 
diagnosis. The mean MASES-R score was 3.2 ± 0.7. 
Most subjects were confident in their ability to take 
their medication between meals (70.5%) or more than 
once a day (59.1%). In addition, the majority reported 
that they would continue to take the medication even 
when they were worried about having to take it for the 
rest of their lives (54.5%) or when they did not have any 
symptoms (54.5%) or felt well (52.3%). The Cronbach’s 
alpha values of the MMAS, the necessity and concerns 
subscales of the BMQ, BIPQ and MASES-R tools were 
0.72, 0.78, 0.70, 0.68 and 0.90, respectively.
No significant correlations were observed 
between medication adherence and the demographic 
characteristics of the sample. However, there was a 
significant negative correlation between health beliefs 
Table 1: Demographic characteristics and medication 
adherence and health belief scores* of Omani patients 
with hypertension at four primary health centres in 
Oman (N = 45)
Variable n (%)




Mean number of years with HTN 
(range)
7.3 ± 6.9 (1–30)
Mean number of antihypertensive 
medications prescribed (range)
1.9 ± 1.1 (1–5)
Mean frequency of daily dose 
(range)
1.6 ± 0.80 (1–4)
Residence 














Ability to read and write only 4 (8.9)
Primary or preparatory 4 (8.9)
High school 12 (26.7)
University or higher 6 (13.3)
Employment status‡
Government sector 7 (15.6)










Mean adherence and health belief scores (range)
MMAS 5.3 ± 2.0 (0.75–8.0)
BMQ-C 2.7 ± 0.7 (1.2–4.7)
BMQ-N 3.8 ± 0.8 (2.0–5.0)
BIPQ 27.0 ± 12.2 (1.0–56.0)
MASES-R 3.2 ± 0.7 (1.6–4.0)
HTN = hypertension; OMR = Omani rials; MMAS = Morisky 
Medication Adherence Scale; BMQ-C = Beliefs about Medicine 
Questionnaire concerns subscale; BMQ-N = Beliefs about Medicine 
Questionnaire necessity subscale; BIPQ = Brief Illness Perception 
Questionnaire; MASES-R = revised Medication Adherence Self-
Efficacy Scale.
*Medication adherence was assessed using an Arabic version of the 
8-item Morisky Medication Adherence Scale while health beliefs were 
assessed using Arabic versions of the 11-item Beliefs about Medicine 
Questionnaire, 8-item Brief Illness Perception Questionnaire and 
13-item revised Medication Adherence Self-Efficacy Scale.7–10,12
†Total dataset for this variable was 43 as information for two subjects 
was unavailable.
‡Total dataset for this variable was 44 as information for one subject 
was unavailable.
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regarding perceived HTN severity and medication 
adherence (r = −0.32; P = 0.030) and a significant 
positive correlation between perceived self-efficacy 
and medication adherence (r = 0.44; P = 0.003). No 
significant correlation was found between medication 
adherence and beliefs about medication necessity 
(r = 0.25; P = 0.100) or medication concerns (r = -0.28; 
P = 0.060). The regression model was significant 
(F(4,39) = 4.89; P = 0.003) and explained 33.0% of the 
variation in medication adherence. Self-efficacy 
(B = 1.067; P = 0.012) and beliefs about medication 
necessity (B = 0.777; P = 0.028) were positively 
associated with medication adherence [Table 2]. 
Self-efficacy and necessity together explained 26.0% 
of the variation in medication adherence.
Discussion
In the current study, the overall adherence rate was 
less than 50%, which is consistent with reports from 
the World Health Organization and indicative of the 
need for collaborative efforts to improve medication 
adherence in Oman.1 High self-efficacy was significantly 
associated with medication adherence among Omani 
patients with HTN, a finding which is consistent with 
that reported in the literature, regardless of differences 
in measures, study designs or culture.8,14 Self-efficacy 
is a critical factor in creating and sustaining health 
behaviours because it empowers individuals, giving 
them confidence in maintaining positive health 
behaviours (e.g. medication adherence).15 Such 
findings highlight the fact that self-efficacy needs to be 
a central component in ensuring medication adherence 
across cultures and populations. The current study 
also found that stronger beliefs about the necessity of 
antihypertensive medications were related to higher 
medication adherence; other studies, including those 
involving Arab populations, have reported similar 
results.2,14 
No relationship was found between concerns 
about antihypertensive medications and medication 
adherence in the present study; this is inconsistent with 
the findings of previous research.2,14 In the current study, 
subjects seemed more anxious about becoming overly 
dependent on their medications. It is likely that the 
low adherence level noted among patients with more 
concerns about their medications could be improved by 
addressing these fears when developing a plan of care, 
particularly with major concerns related to the long-
term consequences or side-effects of the medication 
or fears of dependency. When planning programmes 
that target health behaviour, the contextual meaning of 
health to an individual, including their health beliefs, is 
significant.3 Furthermore, it is crucial to incorporate 
health beliefs and self-efficacy as key components of 
health education or counselling programmes designed 
for members of the general public in Oman. 
This pilot study was subject to certain limitations. 
As a cross-sectional correlational study design was 
used, causal relationships and long-term adherence 
rates could not be inferred. Additionally, the small 
sample size, use of convenience sampling to recruit 
the subjects and sole inclusion of patients with HTN 
limited the generalisability of the findings to the larger 
Omani population and increased the likelihood of 
selection bias. Furthermore, the use of a self-reported 
measure to examine medication adherence could 
have caused recall bias and an overestimation of 
actual adherence rates. Therefore, additional studies 
with objective measures of medication adherence are 
needed. Future studies using a longitudinal design 
with a larger and randomised sample from different 
regions of Oman are recommended to improve 
the generalisability of these findings and examine 
medication adherence over time.
Table 2: Linear regression analysis* of health belief variables predicting medication adherence† among Omani 
patients with hypertension at four primary health centres in Oman (N = 45)




t P value 95% CI
BIPQ -0.034 ± -0.024 -0.211 -1.389 0.173 -0.83–0.15
MASES-R 1.067 ± 0.405 0.363 2.363 0.012 0.25–1.89
BMQ-C -0.303 ± -0.402 -0.112 -0.755 0.455 -1.12–0.51
BMQ-N 0.777 ± 0.339 0.303 2.289 0.028 0.09–1.46
SE = standard error; CI = confidence interval; BIPQ = Brief Illness Perception Questionnaire; MASES-R = revised Medication Adherence Self-
Efficacy Scale; BMQ-C = Beliefs about Medicine Questionnaire concerns subscale; BMQ-N = Beliefs about Medicine Questionnaire necessity 
subscale.
*R2 = 0.33. †Health beliefs were assessed using Arabic versions of the 11-item Beliefs about Medicine Questionnaire, 8-item Brief Illness Perception 
Questionnaire and 13-item revised Medication Adherence Self-Efficacy Scale while medication adherence was assessed using an Arabic version of the 
8-item Morisky Medication Adherence Scale.7–10,12
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Conclusion
This pilot study was conducted to examine the 
relationship between Omani patients’ health beliefs 
and their antihypertensive medication adherence. 
Overall, health beliefs regarding the necessity of 
the medication and perceived self-efficacy were 
significantly associated with medication adherence. 
These findings could be used to develop health 
education programmes on HTN management based 
on health beliefs to help improve overall adherence to 
HTN medications in Oman. 
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